Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Document › Details

bioMérieux S.A.. (8/30/17). "Press Release: First-Half 2017 Results". Marcy l’Étoile.

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product in vitro diagnostics (IVD)
  Product 2 molecular diagnostics
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Solid sales dynamic, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation:
–– €1,134 million in sales
–– Up 13.3% as reported

> 30-bp improvement in contributive operating margin before non-recurring items, which came out at 15.2% of sales

> Sharp 18% increase in net income to €101 million

> 2017 financial targets revised:
–– Organic growth in sales of between 9% and 10%
–– Contributive operating income before non-recurring items of between €330 million and €345 million

Alexandre Mérieux, Chief Executive Officer, said: "bioMérieux has achieved very satisfactory sales and operating results for the first six months of the year. In light of this dynamic performance, as well as the more-favorable-than-expected currency environment, we are able to revise our full-year financial targets upward while pursuing our innovation and development efforts for the long term."

Download [ ]

Record changed: 2017-09-06


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

More documents for Mérieux (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top